0001831942-26-000025.txt : 20260515
0001831942-26-000025.hdr.sgml : 20260515
20260515163657
ACCESSION NUMBER: 0001831942-26-000025
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20260331
FILED AS OF DATE: 20260515
DATE AS OF CHANGE: 20260515
EFFECTIVENESS DATE: 20260515
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Commodore Capital LP
CENTRAL INDEX KEY: 0001831942
ORGANIZATION NAME:
EIN: 832659606
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-20976
FILM NUMBER: 26988798
BUSINESS ADDRESS:
STREET 1: 444 MADISON AVENUE
STREET 2: 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-256-8600
MAIL ADDRESS:
STREET 1: 444 MADISON AVENUE
STREET 2: 35TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
FORMER COMPANY:
FORMER CONFORMED NAME: COMMODORE CAPITAL LP
DATE OF NAME CHANGE: 20201110
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
false
false
false
0001831942
XXXXXXXX
03-31-2026
03-31-2026
Commodore Capital LP
444 MADISON AVENUE
35TH FLOOR
NEW YORK
NY
10022
13F HOLDINGS REPORT
028-20976
000304370
801-117168
N
Michael Kramarz
Managing Partner
212-256-8600
Michael Kramarz
New York
NY
05-15-2026
0
36
1728452370
false
INFORMATION TABLE
2
commodoreq1202613f.xml
ALKERMES PLC
SHS
G01767105
148512000
4200000
SH
SOLE
4200000
0
0
ALTO NEUROSCIENCE INC
COM SHS
02157Q109
61217446
2723196
SH
SOLE
2723196
0
0
AMYLYX PHARMACEUTICALS INC
COM
03237H101
78535000
5650000
SH
SOLE
5650000
0
0
AN2 THERAPEUTICS INC
COM
037326105
7981298
2333713
SH
SOLE
2333713
0
0
ASSEMBLY BIOSCIENCES INC
COM NEW
045396207
27750000
1000000
SH
SOLE
1000000
0
0
AVALO THERAPEUTICS INC
COM NEW
05338F306
7211190
483000
SH
SOLE
483000
0
0
CELLDEX THERAPEUTICS INC NEW
COM NEW
15117B202
85536660
2696616
SH
SOLE
2696616
0
0
COGENT BIOSCIENCES INC
COM
19240Q201
111159389
2888007
SH
SOLE
2888007
0
0
CORVUS PHARMACEUTICALS INC
COM
221015100
33045293
2258735
SH
SOLE
2258735
0
0
DAMORA THERAPEUTICS INC
COM NEW
36322Q206
50220100
1939000
SH
SOLE
1939000
0
0
DEFINIUM THERAPEUTICS INC
COM SHS
24477V105
37800000
2000000
SH
SOLE
2000000
0
0
ENLIVEN THERAPEUTICS INC
COM
29337E102
128380000
3275000
SH
SOLE
3275000
0
0
ERASCA INC
COM
29479A108
51371500
3175000
SH
SOLE
3175000
0
0
EYEPOINT INC
COM NEW
30233G209
36414250
2825000
SH
SOLE
2825000
0
0
HELIX ACQUISITION CORP III
USD CL A ORD SHS
G4444S107
5080000
500000
SH
SOLE
500000
0
0
INHIBIKASE THERAPEUTICS INC
COM NEW
45719W205
9067780
5397488
SH
SOLE
5397488
0
0
KARYOPHARM THERAPEUTICS INC
COM NEW
48576U205
10861500
1950000
SH
SOLE
1950000
0
0
KYMERA THERAPEUTICS INC
COM
501575104
62467500
750000
SH
SOLE
750000
0
0
LB PHARMACEUTICALS INC
COM SHS
50180M108
36990000
1500000
SH
SOLE
1500000
0
0
NURIX THERAPEUTICS INC
COM
67080M103
35262500
2275000
SH
SOLE
2275000
0
0
NUVALENT INC
COM
670703107
85402320
833600
SH
SOLE
833600
0
0
OCULAR THERAPEUTIX INC
COM
67576A100
21810250
2575000
SH
SOLE
2575000
0
0
PALISADE BIO INC
COM
696389402
12566859
7181062
SH
SOLE
7181062
0
0
PEPGEN INC
COM
713317105
7920750
4475000
SH
SOLE
4475000
0
0
PERSPECTIVE THERAPEUTICS INC
COM NEW
46489V302
26424381
6336782
SH
SOLE
6336782
0
0
PHARVARIS N V
COM
N69605108
54210903
1918970
SH
SOLE
1918970
0
0
RELAY THERAPEUTICS INC
COM
75943R102
169150000
17000000
SH
SOLE
17000000
0
0
RELMADA THERAPEUTICS INC
COM
75955J402
4411951
633901
SH
SOLE
633901
0
0
SAB BIOTHERAPEUTICS INC
COM NEW
78397T202
16857745
4401500
SH
SOLE
4401500
0
0
SOLENO THERAPEUTICS INC
COM
834203309
21843423
652432
SH
SOLE
652432
0
0
SPYRE THERAPEUTICS INC
COM NEW
00773J202
96460447
1912380
SH
SOLE
1912380
0
0
TYRA BIOSCIENCES INC
COM
90240B106
94792500
2475000
SH
SOLE
2475000
0
0
XENON PHARMACEUTICALS INC
COM
98420N105
47973750
825000
SH
SOLE
825000
0
0
ZURA BIO LTD
CLASS A ORD SHS
G9TY5A101
19337500
3250000
SH
SOLE
3250000
0
0
CENTURY THERAPEUTICS INC
COM
15673T100
19652174
8695652
SH
SOLE
8695652
0
0
LEONABIO INC
COM
04746L203
4774011
464398
SH
SOLE
464398
0
0